Drugs / QR-bromocriptine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01474018 | Nov 2011 → May 2012 | type 2 diabetes mellitus | University of Texas Southwestern Medical Center | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QR-bromocriptine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01474018 ↗ |